Tools
Tools
Arora, A., Abdel-Fatah, T.M.A., Agarwal, D., Doherty, R., Croteau, D.L., Moseley, P.M., Hameed, K., Green, A., Aleskandarany, M.A., Rakha, E.A., Patterson, K., Ball, G. 
ORCID: 0000-0001-5828-7129, Chan, S.Y.T., Ellis, I.O., Bohr, V.A., Bryant, H.E. and Madhusudan, S.,
2016.
Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers.
Carcinogenesis, 37 (1), pp. 63-71.
ISSN 0143-3334
|
Text
4324_Ball.pdf - Post-print Download (455kB) | Preview |
Abstract
RECQL5 is a member of the RecQ family of DNA helicases and has key roles in homologous recombination, base excision repair, replication and transcription. The clinicopathological significance of RECQL5 expression in breast cancer is unknown. In the current study we have evaluated RECQL5 mRNA expression in 1977 breast cancers, and RECQL5 protein level in 1902 breast cancers [Nottingham Tenovus series (n=1650) and ER- cohort (n=252)]. Expression levels were correlated to aggressive phenotypes and survival outcomes. High RECQL5 mRNA expression was significantly associated with high histological grade (p=0.007), HER2 overexpression (p=0.032), ER+/HER2-/high proliferation genefu subtype, integrative molecular clusters (intClust 1and 9) and poor breast cancer specific survival (BCSS) (ps<0.0001). In sub-group analysis, high RECQL5 mRNA level remains significantly associated with poor BCSS in ER+ cohort (p<0.0001) but not in ER- cohort (p=0.116). At the protein level, in tumours with low RAD51, high RECQL5 level was significantly associated with high histological grade (p<0.0001), higher mitotic index (p=0.008), de-differentiation (p=0.025), pleomorphism (p=0.027) and poor BCSS (P=0.003). In sub-group analysis, high RECQL5/low RAD51 remains significantly associated with poor BCSS in ER+ cohort (p=0.010), but not in ER- cohort (p=0.628). In multivariate analysis, high RECQL5 mRNA and high RECQL5/low RAD51 nuclear protein co-expression independently influenced BCSS (p=0.022) in whole cohort and in the ER+ sub-group. Pre-clinically, we show that exogenous expression of RECQL5 in MCF10A cells can drive proliferation supporting an oncogenic function for RECQL5 in breast cancer. We conclude that RECQL5 is a promising biomarker in breast cancer.
| Item Type: | Journal article | ||||
|---|---|---|---|---|---|
| Publication Title: | Carcinogenesis | ||||
| Creators: | Arora, A., Abdel-Fatah, T.M.A., Agarwal, D., Doherty, R., Croteau, D.L., Moseley, P.M., Hameed, K., Green, A., Aleskandarany, M.A., Rakha, E.A., Patterson, K., Ball, G., Chan, S.Y.T., Ellis, I.O., Bohr, V.A., Bryant, H.E. and Madhusudan, S. | ||||
| Publisher: | Oxford University Press | ||||
| Date: | January 2016 | ||||
| Volume: | 37 | ||||
| Number: | 1 | ||||
| ISSN: | 0143-3334 | ||||
| Identifiers: |
|
||||
| Divisions: | Schools > School of Science and Technology | ||||
| Record created by: | Jonathan Gallacher | ||||
| Date Added: | 09 Feb 2016 15:02 | ||||
| Last Modified: | 07 Jun 2019 08:26 | ||||
| URI: | https://irep.ntu.ac.uk/id/eprint/26917 |
Actions (login required)
 |
Edit View |
Views
Views per month over past year
Downloads
Downloads per month over past year
